- Home
- TRIN vs CRMD Comparison
TRIN vs CRMD Comparison
Compare TRIN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIN
- CRMD
- Stock Information
- Founded
- TRIN 2007
- CRMD 2006
- Country
- TRIN United States
- CRMD United States
- Employees
- TRIN N/A
- CRMD N/A
- Industry
- TRIN Finance/Investors Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- TRIN Finance
- CRMD Health Care
- Exchange
- TRIN Nasdaq
- CRMD Nasdaq
- Market Cap
- TRIN 974.3M
- CRMD 877.5M
- IPO Year
- TRIN 2021
- CRMD 2010
- Fundamental
- Price
- TRIN $14.96
- CRMD $11.54
- Analyst Decision
- TRIN Hold
- CRMD Strong Buy
- Analyst Count
- TRIN 3
- CRMD 7
- Target Price
- TRIN $15.17
- CRMD $17.33
- AVG Volume (30 Days)
- TRIN 751.2K
- CRMD 1.8M
- Earning Date
- TRIN 08-06-2025
- CRMD 08-13-2025
- Dividend Yield
- TRIN 13.64%
- CRMD N/A
- EPS Growth
- TRIN 37.77
- CRMD N/A
- EPS
- TRIN 2.19
- CRMD 0.28
- Revenue
- TRIN $240,010,000.00
- CRMD $82,553,827.00
- Revenue This Year
- TRIN $24.11
- CRMD $278.96
- Revenue Next Year
- TRIN $4.87
- CRMD $45.85
- P/E Ratio
- TRIN $6.83
- CRMD $41.21
- Revenue Growth
- TRIN 30.65
- CRMD N/A
- 52 Week Low
- TRIN $12.50
- CRMD $3.61
- 52 Week High
- TRIN $16.82
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- TRIN 59.21
- CRMD 46.04
- Support Level
- TRIN $14.58
- CRMD $10.70
- Resistance Level
- TRIN $15.14
- CRMD $12.07
- Average True Range (ATR)
- TRIN 0.22
- CRMD 0.47
- MACD
- TRIN 0.02
- CRMD 0.09
- Stochastic Oscillator
- TRIN 77.99
- CRMD 61.31
About TRIN Trinity Capital Inc.
Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.